US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q2 2026)
- 58
- Value
- $815
- % of portfolio
- <0.1%
- Quarters held
- 14
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 58 | $815 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 58 | $1.16K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 58 | $1.78K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 58 | $942 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 58 | $513 | <0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 1,165 | $627 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1,165 | $746 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1,165 | $1.61K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1,165 | $1.69K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1,165 | $2.60K | <0.1% | +1,165 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −2,361−100.0% | Sold out | Holders |
| Q3 2023 | 2,361 | $3.47K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 2,361 | $7.51K | <0.1% | +1,529+183.8% | Added | Holders |
| Q1 2023 | 832 | $1.96K | <0.1% | +83+11.1% | Added | Holders |
| Q4 2022 | 749 | $2.60K | <0.1% | +749 | New | Holders |